Skip to content

Traditional Chinese medicine (Liang-Xue-Di-Huang Decoction ) for hemorrhoid hemorrhage: a randomized, controlled, double blind, double simulation and multi-center trial

traditional chinese colo-proctology—Traditional Chinese medicine (Liang-Xue-Di-Huang Decoction ) for hemorrhoid hemorrhage: a randomized, controlled, double blind, double simulation and multi-center trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022531
Enrollment
Unknown
Registered
2019-04-15
Start date
2019-05-31
Completion date
Unknown
Last updated
2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemorrhoid

Interventions

Sponsors

Affiliated Hospital of Nanjing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Comply with hemorrhoids stage I, stage ?, ? diagnosis standards; 2. Comply with "Traditional Chinese Medicine Disease and Syndrome Diagnosis and Curative Effect Standard" wind injury intestinal or damp-heat staining syndrome:hemorrhoid hemorrhage was jet or drip down, blood color red; 3. Patients who signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Accompanied by severe liver and kidney, heart and brain lung dysfunction, coagulation dysfunction; 2. Previous medical history or colonoscopy highly suggested IBD patients; 3. Accompanied by inflammatory external hemorrhoids; 4. Acute haemorrhoidal episodess; 5. Patients with perianal abscess, anal fistula, rectal polyp, intestinal tumor or intestinal infectious disease; 6. Patients with pregnancy plan in the first 1 month, during the study and 6 months after the study were screened; 7. Pregnant or lactating women; 8. Those who are allergic to the test drugs and their ingredients; 9. Other patients considered unsuitable for enrollment by the researchers.

Design outcomes

Primary

MeasureTime frame
French bleeding score;

Secondary

MeasureTime frame
goligher prolapse score;quality-of-life score;

Countries

China

Contacts

Public ContactYugen Chen

Affiliated Hospital of Nanjing University of Chinese Medicine

chenyg666@126.com+86 13701409418

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026